Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharlene Gill

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Current Oncology (Toronto, Ont.)|March 11, 2021
Current Oncology: A Multidisciplinary Medium for Clinical OncologySharlene Gill
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|October 23, 2014
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversiesSharlene Gill
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Reply to M. Uccello et alSharlene Gill
The Oncologist|June 24, 2006
End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?Sharlene Gill, Daniel Sargent
Therapeutic Advances in Medical Oncology|April 3, 2023
Controversies and management of deficient mismatch repair gastrointestinal cancers in the neoadjuvant settingMélina Boutin, Sharlene Gill
Clinical Colorectal Cancer|June 27, 2006
Capecitabine-induced cerebellar toxicityDaniel Renouf, Sharlene Gill
Diseases of the Colon and Rectum|February 27, 2008
Patterns of diagnosis for colorectal cancer: screening detected vs. symptomatic presentationSasha Smiljanic, Sharlene Gill
Seminars in Oncology|February 24, 2005
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?Sharlene Gill, Frank A Sinicrope
Current Oncology Reports|April 2, 2003
New developments in therapy for colorectal cancerSharlene Gill, Richard M Goldberg
Medical Oncology (Northwood, London, England)|August 4, 2010
Presentation and outcomes of patients aged 30 years and younger with colorectal cancer: a 20-year retrospective reviewJasem Al-Barrak, Sharlene Gill
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Current Oncology (Toronto, Ont.)|March 11, 2021
Current Oncology: A Multidisciplinary Medium for Clinical OncologySharlene Gill
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|October 23, 2014
Adjuvant therapy for resected high-risk colon cancer: Current standards and controversiesSharlene Gill
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2017
Reply to M. Uccello et alSharlene Gill
The Oncologist|June 24, 2006
End points for adjuvant therapy trials: has the time come to accept disease-free survival as a surrogate end point for overall survival?Sharlene Gill, Daniel Sargent
Therapeutic Advances in Medical Oncology|April 3, 2023
Controversies and management of deficient mismatch repair gastrointestinal cancers in the neoadjuvant settingMélina Boutin, Sharlene Gill
Clinical Colorectal Cancer|June 27, 2006
Capecitabine-induced cerebellar toxicityDaniel Renouf, Sharlene Gill
Diseases of the Colon and Rectum|February 27, 2008
Patterns of diagnosis for colorectal cancer: screening detected vs. symptomatic presentationSasha Smiljanic, Sharlene Gill
Seminars in Oncology|February 24, 2005
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?Sharlene Gill, Frank A Sinicrope
Current Oncology Reports|April 2, 2003
New developments in therapy for colorectal cancerSharlene Gill, Richard M Goldberg
Medical Oncology (Northwood, London, England)|August 4, 2010
Presentation and outcomes of patients aged 30 years and younger with colorectal cancer: a 20-year retrospective reviewJasem Al-Barrak, Sharlene Gill
Pageof 16